Meta Pixel

News and Announcements

Select 3D, an Australian 3D technology company, has designed and developed a dishwasher safe faceshield kit

  • Published March 25, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

“Pretty Woman walking down the street” What was Roy Orbinson singing?

Select 3D completes research and development into a dishwasher safe 3D printing application of engineered medical materials for the health-conscious.

Register Interest

Select 3D, an Australian 3D technology company, has designed and developed a dishwasher safe faceshield kit which is not only suitable for residential use, but the designer face shield is suitable for travel, first aid kits and provides added protection against flues & covid -19 (corona virus).  The design is half the price of Louis Vuitton designer personal protective equipment and practical.

Medical Dr. V. Bharatula, who recently returned to Australia says Select 3D’s faceshield is “light weight & comfortable” – 2021.

Select 3D’s founder, Anuja Rao, is thrilled to inform existing and prospective sophisticated and professional investors of this exciting news. “The faceshield frame forms the future platform for its spectacle and smart glasses range which will appeal to future generations including the industrial sector.  This product range lends itself to integration into mixed reality software and custom resizing applications.”

Keep Safe, Spread the Word not the Virus.

Select 3D Pty Ltd

Select 3D is a 3D technology, 3D printing/manufacturing, mixed reality and consultancy company.

Select 3D is largely project oriented and is targeting a broad range of sectors that have limited exposure to 3D printed services and products. By being project oriented, Select 3D can remain technology agnostic by matching industry demand to the best 3D printing technologies available.

Register Interest

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now